Diffuse Alveolar Hemorrhage Associated with Edoxaban Therapy
Introduction. The main adverse effect of anticoagulant therapy is bleeding, and major bleeding, including intracranial, gastrointestinal, and retroperitoneal bleeding, has been reported as an adverse effect of edoxaban, a direct oral anticoagulant (DOAC). Bleeding during systemic anticoagulation wit...
Saved in:
Main Authors: | Kenichi Nitta, Hiroshi Imamura, Akihiro Yashio, Satoko Kashima, Katsunori Mochizuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2016/7938062 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diffuse Alveolar Hemorrhage Associated with Warfarin Therapy
by: Bülent Kaya, et al.
Published: (2015-01-01) -
Surgery for Bacterial Endocarditis Complicated by Diffuse Alveolar Hemorrhage
by: Kazuhiro Kurisu, et al.
Published: (2019-01-01) -
Diffuse Alveolar Hemorrhage Induced by Vaping
by: Michael Agustin, et al.
Published: (2018-01-01) -
Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
by: Walavan Sivakumar, et al.
Published: (2013-01-01) -
Diffuse Alveolar Hemorrhage in a Patient with Antisynthetase Syndrome
by: D. A. Vargas-Gutiérrez, et al.
Published: (2019-01-01)